Not known Details About Healthcare News
Novo CEO pressed by Senate to cut price ranges of being overweight, diabetic issues medication CEO Lars Fruergaard Jørgensen advised lawmakers the company would look at new talks with insurers regarding the list price ranges of Wegovy and copyright if they pledge to help keep the medicines on their formularies.The deal should be completed by Sept.